Who / What
Ginkgo Bioworks is an American biotechnology company that specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies. The company saves other companies the cost of reproducing the initial stages of design in synthetic biology.
Background & History
Ginkgo Bioworks Holdings, Inc. was founded in 2008 by five scientists from MIT, with Jason Kelly serving as the head of the company. The company emerged during a period of growth in biotechnology and synthetic biology applications. Since its founding, it has established itself as a major player in the field of engineered organism design.
Why Notable
Ginkgo Bioworks has gained recognition for its unique business model in the biotechnology sector, focusing on being an "operating system for biology." The company has made significant contributions to synthetic biology by enabling other companies to access sophisticated genetic engineering capabilities without developing the infrastructure themselves. Its work has accelerated innovation across multiple industries including pharmaceuticals, agriculture, and industrial chemicals.
In the News
The company continues to be a significant player in the biotechnology sector, with ongoing developments in engineered organism applications. Its growth and partnerships remain closely watched indicators of the synthetic biology industry's expansion and commercial viability.
